NLRP3 and acute respiratory distress syndrome: There is clear evidence that inhibiting the NLRP3 inflammasome reduces inflammatory responses [13], and NLRP3 inflammasome antagonists have mostly been successful in treating rI/R [14–16], but their effects on rI/R-induced ALI have not been reported.